Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
City of Hope Medical Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Toray Industries, Inc
National Cancer Institute (NCI)
Eli Lilly and Company
Kyowa Kirin Co., Ltd.
City of Hope Medical Center
AstraZeneca
National Cancer Institute (NCI)
Masonic Cancer Center, University of Minnesota
Altor BioScience
Dartmouth-Hitchcock Medical Center
GOG Foundation
National Cancer Institute (NCI)
Astellas Pharma Inc
Memorial Sloan Kettering Cancer Center